Next Article in Journal
Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs)
Next Article in Special Issue
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies
Previous Article in Journal
Preferences of Healthcare Professionals on 3D-Printed Tablets: A Pilot Study
Previous Article in Special Issue
VEGF Overexpression Significantly Increases Nanoparticle-Mediated siRNA Delivery and Target-Gene Downregulation
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(8), 1523; https://doi.org/10.3390/pharmaceutics14081523
Action Date Notes Link
article xml file uploaded 22 July 2022 08:22 CEST Original file -
article xml uploaded. 22 July 2022 08:22 CEST Update -
article pdf uploaded. 22 July 2022 08:22 CEST Version of Record -
article supplementary file uploaded. 22 July 2022 08:22 CEST - https://www.mdpi.com/1999-4923/14/8/1523#supplementary
article html file updated 22 July 2022 08:24 CEST Original file -
article xml file uploaded 22 July 2022 09:53 CEST Update -
article xml uploaded. 22 July 2022 09:53 CEST Update https://www.mdpi.com/1999-4923/14/8/1523/xml
article pdf uploaded. 22 July 2022 09:53 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1523/pdf
article html file updated 22 July 2022 09:54 CEST Update -
article supplementary file uploaded. 4 August 2022 03:49 CEST - https://www.mdpi.com/1999-4923/14/8/1523#supplementary
article html file updated 4 August 2022 03:50 CEST Update -
article supplementary file uploaded. 5 August 2022 03:59 CEST - https://www.mdpi.com/1999-4923/14/8/1523#supplementary
article html file updated 5 August 2022 04:00 CEST Update -
article html file updated 13 August 2022 03:04 CEST Update https://www.mdpi.com/1999-4923/14/8/1523/html
Back to TopTop